Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Martin Hughes, Toscafund Management Strenghten Position in LSE-listed Sinclair IS Pharma

Martin Hughes‘ hedge fund Toscafund Management has solidified its exposure at the LSE-listed Sinclair IS Pharma PLC (LON:SPH). According to a filing, Toscafund now holds over 91.7 million shares, which represent almost 21.1% of the company’s total voting rights. The position has been upped from 90.6 million held by Toscafund earlier.

Sinclair IS Pharma PLC (SPH)

According to Sinclair’s website, Toscafund is the largest shareholder of the company. Some smaller positions are held by AXA Investment Managers, and Lansdowne Partners, managed by Paul Ruddock and Steve Heinz, which holds around 50 million shares, or 11.5% of the voting rights.

Sinclair IS Pharma is engaged in production of various pharmaceutical products for dermatology. Recently the company announced about the disposal of some of its non-core products. The company sold its Effederm, for acne treatment, to Labaratoires Bailleul SA. Other three products: Xclair,
Salinum and SST have been acquired by Hexim Pharmaceuticals Inc. The total proceeds from the deals amount to over $1.7 million.

For the fiscal year 2013, ended on June 30, Sinclair reported revenues of over $89 million, which represent a 7.7% increase over the year. The gross profit of the company totaled $50.7 million, up by 7.9% in year-on-year terms. The stock of the company has gained over 9% since the beginning of the year.

Martin Hughes, the manager of Toscafund, is a former employee of Julian Roberton’s hedge fund Tiger Management. Among a wide range of investments, one of the oldest funds managed by Toscafund is the global long/short equity fund. Among the largest holdings in its equity portfolio, we can mention Citigroup Inc. (NYSE:C), in which the fund owns 778,900 shares, with a value of $37.8 million; followed by Hartford Financial Services Group Inc (NYSE:HIG), and SLM Corp (NASDAQ:SLM), in which Toscafund reported holding 754,300 shares, and 817,400 shares, worth $23.5 million and $20.4 million respectively.

Disclosure: none

Recommended Reading:

J. Carlo Cannell, Cannell Capital Trim Stake in Crumbs Bake Shop

Prescott Group Capital Management Continues Bullish Streak on China Marine Food Group

Coliseum Capital Keeps Increasing Stake in Accuride



Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!